"There have been some encouraging results with the use of hyperbaric oxygen therapy for long COVID," said Dr. Amesh Adalja, an infectious disease specialist and senior scholar at the Johns Hopkins Center for Health Security. "However, there is still more study necessary to be able to conclude that this is a definitively positive treatment."
Study finds oxygen therapy effective for long COVID up to a year later
→
"Hospitalization costs for COVID are not trivial and comorbid conditions increase that cost," Dr. Adalja, an infectious disease specialist, told The Times. "The study demonstrates that prevention of hospitalization is not only beneficial to health but has an economic impact as well."
JAMA Network Open study finds average COVID hospital stay cost more than $11,000
→